Eikon Therapeutics Ord Shs

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Eikon Therapeutics Ord Shs had 161.15M in cash and cash equivalents.

Eikon Therapeutics Ord Shs reported 312.30M in total liabilities as of the latest reported quarter, including 55.01M in current liabilities and 257.29M in non-current liabilities.

As of the latest reported quarter, Eikon Therapeutics Ord Shs's total assets were 594.73M, consisting of 348.92M in current assets and 245.82M in non-current assets.

Eikon Therapeutics Ord Shs reported 282.44M in total shareholders' equity as of the latest reported quarter.